The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
Open accessAbstract
BACKGROUND: The acute chest syndrome is the leading cause of death among patients with sickle cell disease. Since its cause is largely unknown, therapy is supportive. Pilot studies with improved diagnostic techniques suggest that infection and fat embolism are underdiagnosed in patients with the syndrome. METHODS: In a 30-center study, we analyzed 671 episodes of the acute chest syndrome in 538 patients with sickle cell disease to determine the cause, outcome, and response to therapy. We evaluated a treatment protocol that included matched transfusions, bronchodilators, and bronchoscopy. Samples of blood and respiratory tract secretions were sent to central laboratories for antibody testing, culture, DNA testing, and histopathological analyses. RESULTS: Nearly half the patients were initially admitted for another reason, mainly pain. When the acute chest syndrome was diagnosed, patients had hypoxia, decreasing hemoglobin values, and progressive multilobar pneumonia. The mean length of hospitalization was 10.5 days. Thirteen percent of patients required mechanical ventilation, and 3 percent died. Patients who were 20 or more years of age had a more severe course than those who were younger. Neurologic events occurred in 11 percent of patients, among whom 46 percent had respiratory failure. Treatment with phenotypically matched transfusions improved oxygenation, with a 1 percent rate of alloimmunization. One fifth of the patients who were treated with bronchodilators had clinical improvement. Eighty-one percent of patients who required mechanical ventilation recovered. A specific cause of the acute chest syndrome was identified in 38 percent of all episodes and 70 percent of episodes with complete data. Among the specific causes were pulmonary fat embolism and 27 different infectious pathogens. Eighteen patients died, and the most common causes of death were pulmonary emboli and infectious bronchopneumonia. Infection was a contributing factor in 56 percent of the deaths. CONCLUSIONS: Among patients with sickle cell disease, the acute chest syndrome is commonly precipitated by fat embolism and infection, especially community-acquired pneumonia. Among older patients and those with neurologic symptoms, the syndrome often progresses to respiratory failure. Treatment with transfusions and bronchodilators improves oxygenation, and with aggressive treatment, most patients who have respiratory failure recover.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epidemiologically, ACS is a complication of VOC, based on its typical development 2–3 days after the onset of vaso-occlusive pain (111)”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [111]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it is more common in children and, if untreated, has a high mortality [9% in adults (111)].”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [111]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Rickinson, A. B. (2002) · PubMed · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,182
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients
Cook, D. J., Walter, S. D., Cook, R. J., Griffith, L. E., Guyatt, G. H., Leasa, D., Jaeschke, R. Z., & Brun‐Buisson, C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-6-199809150-00002 · Cited by 1,108
Castro, O. L., Brambilla, D. J., Thorington, B. D., Reindorf, C. A., Scott, R., GILLETTE, P. N., Vera, J., & Levy, P. S. (1994) · Blood · doi:10.1182/blood.v84.2.643.643 · Cited by 805
Vichinsky, E. P., Haberkern, C. M., Neumayr, L., Earles, A. N., Black, D. M., Koshy, M., Pegelow, C. H., Abboud, M. R., Ohene‐Frempong, K., & Iyer, R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330402 · Cited by 644
Self-citationCastro, O. L., Brambilla, D. J., Thorington, B. D., et al. (1994) · Blood · doi:10.1182/blood.v84.2.643.bloodjournal842643 · Cited by 615
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573
Self-citationSickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure.
Powars, D., WEIDMAN, J. A., Odom‐Maryon, T., Niland, J. C., & Johnson, C. M. (1988) · PubMed · Cited by 329
Sickle Cell Chronic Lung Disease
Powars, D. R., WEIDMAN, J. A., ODOM-MARYON, T., Niland, J. C., & Johnson, C. S. (1988) · Medicine · doi:10.1097/00005792-198801000-00005 · Cited by 283
Research works printed but not linked: 9
- Vichinsky E, 1991, Semin Hematol, 28, 220
- Sprinkle RH, 1986, Am J Pediatr Hematol Oncol, 8, 105
- Landry ML, Hsiung GD. Primary isolation of viruses. In: Specter S, Lancz G, eds. Clinical virology manual. 2nd ed. New York: Elsevier Science Publishing, 1992:43-69.
- Waites KB, Taylor-Robinson D. Mycoplasma and Ureaplasma. In: Murray PR, ed. Manual of clinical microbiology. 7th ed. Washington, D.C.: ASM Press, 1999:782-806.
- Lennette ET, Lennette DA. Immune adherence hemagglutination. In: Specter S, Lancz G, eds. Clinical virology manual. 2nd ed. New York: Elsevier Science Publishing, 1992:251-61.
- Schachter J. Chlamydiae. In: Balows A, Hausler WJ Jr, Hermann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. Washington, D.C.: ASM Press, 1991:1045-53.
- Ohene-Frempong K, 1998, Blood, 91, 288
- Mallouh AA, 1988, Am J Dis Child, 142, 178
- Ibe BO, 1997, Am J Physiol, 272, L597
Cited by
Sorted by citations
Items 201–300 of 1,000
Serjeant, G. R., Chin, N., Asnani, M., Serjeant, B. E., Mason, K. P., Hambleton, I. R., & Knight‐Madden, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192710 · Cited by 58
Inhaled nitric oxide: Current clinical concepts
Bhatraju, P. K., Crawford, J. H., Hall, M. K., & Lang, J. D. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.08.007 · Cited by 58
An, P., Barron‐Casella, E. A., Strunk, R. C., Hamilton, R. G., Casella, J. F., & DeBaun, M. R. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1114 · Cited by 58
The radiological manifestations of sickle cell disease
Madani, G., Papadopoulou, A. M., Holloway, B., Robins, A., Davis, J., & Murray, D. (2007) · Clinical Radiology · doi:10.1016/j.crad.2007.01.006 · Cited by 57
Chronic Transfusion Therapy for Children With Sickle Cell Disease and Recurrent Acute Chest Syndrome
Hankins, J. S., Jeng, M., Harris, S. C., Li, C., Liu, T., & Wang, W. C. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000157789.73706.53 · Cited by 57
Ballas, S. K. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189002 · Cited by 61
Self-citationAtaga, K. I., & Orringer, E. P. (2000) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200011000-00009 · Cited by 57
Self-citationPrognostic significance of early vaso-occlusive complications in children with sickle cell anemia
Quinn, C. T., Shull, E. P., Ahmad, N., Lee, N. J., Rogers, Z. R., & Buchanan, G. R. (2006) · Blood · doi:10.1182/blood-2006-02-005082 · Cited by 56
Ameen, R. M., Alshemmari, S., & Al‐Bashir, A. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02185.x · Cited by 56
Ghosh, S., Tan, F., & Ofori-Acquah, S. F. (2012) · Anemia · doi:10.1155/2012/582018 · Cited by 55
Pathology of sickle cell disease
Malowany, J. I., & BUTANY, J. W. (2012) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2011.07.005 · Cited by 54
Exchange versus simple transfusion for acute chest syndrome in sickle cell anemia adults
Turner, J. M., Kaplan, J. B., Cohen, H. W., & Billett, H. H. (2009) · Transfusion · doi:10.1111/j.1537-2995.2008.02075.x · Cited by 54
Placenta growth factor in sickle cell disease: association with hemolysis and inflammation
Brittain, J. E., Hulkower, B., Jones, S., Strayhorn, D., Castro, L. D., Telen, M. J., Orringer, E. P., Hinderliter, A. L., & Ataga, K. I. (2009) · Blood · doi:10.1182/blood-2009-04-217950 · Cited by 54
Self-citationCurrent Management of Sickle Cell AnemiaPreprint
McGann, P. T., Nero, A. C., & Ware, R. E. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011817 · Cited by 54
Self-citationStyles, L. A., Wager, C. G., Labotka, R., Smith‐Whitley, K., Thompson, A. A., Lane, P. A., McMahon, L. C., Miller, R. E., Roseff, S. D., Iyer, R. V., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09105.x · Cited by 53
Self-citationHigh resource hospitalizations among children with vaso‐occlusive crises in sickle cell disease
Raphael, J. L., Mei, M., Mueller, B. U., & Giordano, T. P. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23181 · Cited by 53
Hemin Causes Lung Microvascular Endothelial Barrier Dysfunction by Necroptotic Cell Death
Singla, S., Sysol, J. R., Dille, B., Jones, N., Chen, J., & Machado, R. F. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0287oc · Cited by 55
Risks associated with fertility preservation for women with sickle cell anemia
Pecker, L. H., Maher, J. Y., Law, J. Y., Beach, M. C., Lanzkron, S., & Christianson, M. S. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.016 · Cited by 57
Ruhl, A. P., Sadreameli, S. C., Allen, J. L., Bennett, D. P., Campbell, A., Coates, T. D., Diallo, D. A., Field, J. J., Fiorino, E. K., Gladwin, M. T., et al. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201906-433st · Cited by 57
Self-citationStandard management of sickle cell disease complications ☆
Abboud, M. R. (2020) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2019.12.007 · Cited by 56
Self-citationFixler, J., & Styles, L. A. (2002) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(02)00089-5 · Cited by 53
Identification of Sickle Cell Anemia Using Deep Neural Networks
Yeruva, S., Varalakshmi, M. S., Gowtham, B. P., Chandana, Y. H., & Prasad, P. K. (2021) · Emerging Science Journal · doi:10.28991/esj-2021-01270 · Cited by 52
Outcomes of Acute Chest Syndrome in Adult Patients with Sickle Cell Disease: Predictors of Mortality
Allareddy, V., Roy, A., Lee, M. K., Nalliah, R. P., Rampa, S., Allareddy, V., & Rotta, A. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094387 · Cited by 52
SICKLE CELL DISEASE AND INFECTIONS IN HIGH- AND LOW-INCOME COUNTRIES
Cannas, G. (2019) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2019.042 · Cited by 56
Acute chest syndrome in sickle cell disease
Farooq, S., Omar, M. A., & Salzman, G. A. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1464363 · Cited by 56
Glassberg, J., WANG, J. J., Cohen, R. T., Richardson, L. D., & DeBaun, M. R. (2012) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2012.01364.x · Cited by 51
Fartoukh, M. S., Lefort, Y., Habibi, A., Bachir, D., Galactéros, F., Godeau, B., Maître, B., & Brochard, L. J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1907-4 · Cited by 51
Sickle cell anemia in Guadeloupean children: pattern and prevalence of acute clinical events
Tarer, V., Etienne‐Julan, M., Diara, J., Belloy, M., Mukisi-Mukaza, M., Élion, J., & Romana, M. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00590.x · Cited by 51
Ballas, S. K., Files, B. A., Luchtman‐Jones, L., Benjamin, L. J., Swerdlow, P. S., Hilliard, L., Coates, T. D., Abboud, M. R., Wojtowicz‐Praga, S., & Grindel, J. M. (2004) · Hemoglobin · doi:10.1081/hem-120035919 · Cited by 51
Self-citationMekontso Dessap, A., Deux, J.-F., Habibi, A., Abidi, N., Godeau, B., Adnot, S., Brun-Buisson, C., Rahmouni, A., Galacteros, F., & Maitre, B. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-203775 · Cited by 50
Development and validation of a pediatric severity index for sickle cell patients
van den Tweel, X. W., van der Lee, J. H., Heijboer, H., Peters, M., & Fijnvandraat, K. (2010) · American Journal of Hematology · doi:10.1002/ajh.21846 · Cited by 50
Outcomes of Adult Patients With Sickle Cell Disease Admitted to the ICU
Cecchini, J., Lionnet, F., Djibré, M., Parrot, A., Stankovic, K., Girot, R., & Fartoukh, M. S. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000316 · Cited by 50
Alvarez, O. A., Yovetich, N. A., Scott, J. P., Owen, W. C., Miller, S. T., Schultz, W. H., Lockhart, A., Aygün, B., Flanagan, J. M., Bonner, M. J., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23547 · Cited by 50
Self-citationVlieg‐Boerstra, B., der Heide, S. V., Elberink, J. N. G. O., Kluin‐Nelemans, H. C., & Dubois, A. E. J. (2005) · PubMed · Cited by 50
NONRESOLVING PNEUMONIA AND MIMICS OF PNEUMONIA
Rome, L. A., Murali, G., & Lippmann, M. L. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70393-x · Cited by 50
Erythrocytapheresis in children with sickle cell disease and acute chest syndrome
Velasquez, M. P., Mariscalco, M. M., Goldstein, S. L., & Airewele, G. E. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22211 · Cited by 49
Sickle Cell Disease: An Opportunity for Palliative Care Across the Life Span
Wilkie, D. J., Johnson, B., Mack, A. K., Labotka, R., & Molokie, R. E. (2010) · Nursing Clinics of North America · doi:10.1016/j.cnur.2010.03.003 · Cited by 49
Recommandations pratiques de prise en charge de la drépanocytose de l’adulte
Lionnet, F., Arlet, J. B., Bartolucci, P., Habibi, A., Ribeil, J., & Stankovic, K. (2009) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.07.001 · Cited by 49
Red cell exchange: special focus on sickle cell disease
Kim, H. C. (2014) · Hematology · doi:10.1182/asheducation-2014.1.450 · Cited by 48
Shah, N., Bhor, M., Xie, L., Arcona, S., Halloway, R., Paulose, J., & Yüce, H. (2019) · Journal of health economics and outcomes research · doi:10.36469/9667 · Cited by 48
Red Blood Cells: Exchange, Transfuse, or Deplete
Stüssi, G., Buser, A. S., & Holbro, A. (2019) · Transfusion Medicine and Hemotherapy · doi:10.1159/000504144 · Cited by 49
Prospects for primary stroke prevention in children with sickle cell anaemia
Jordan, L. C., Casella, J. F., & DeBaun, M. R. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09005.x · Cited by 47
Hoogenboom, W. S., Alamuri, T. T., McMahon, D. M., Balanchivadze, N., Dabak, V. S., Mitchell, W. B., Morrone, K. A., Manwani, D. G., & Duong, T. Q. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100911 · Cited by 47
Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso‐occlusion
Finnegan, E. M., Turhan, A., Golan, D. E., & Barabino, G. A. (2006) · American Journal of Hematology · doi:10.1002/ajh.20819 · Cited by 47
Haynes, J., Baliga, B. S., Obiako, B. O., Ofori-Acquah, S. F., & Pace, B. S. (2004) · Blood · doi:10.1182/blood-2003-08-2969 · Cited by 47
Anaesthetic care for sickle cell disease
Frietsch, T., Ewen, I., & Waschke, K. F. (2001) · European Journal of Anaesthesiology · doi:10.1046/j.0265-0215.2000.00804.x · Cited by 47
Morphine for the Treatment of Pain in Sickle Cell Disease
Gupta, M., Msambichaka, L. A., Ballas, S. K., & Gupta, K. (2015) · The Scientific World JOURNAL · doi:10.1155/2015/540154 · Cited by 46
Self-citationAdvances in clinical research in sickle cell disease
Hagar, W., & Vichinsky, E. P. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07097.x · Cited by 46
Self-citationKlings, E. S., Christman, B. W., McClung, J. P., Stucchi, A. F., McMahon, L. C., BRAUER, M., & Farber, H. W. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2101020 · Cited by 46
Inflammatory targets of therapy in sickle cell disease
Owusu-Ansah, A. T., Ihunnah, C. A., Walker, A. L., & Ofori-Acquah, S. F. (2015) · Translational research · doi:10.1016/j.trsl.2015.07.001 · Cited by 46
Defining stroke risk in children with sickle cell anaemia
Hoppe, C. C. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05310.x · Cited by 45
New Strategies for the Treatment of Pulmonary Hypertension in Sickle Cell Disease
Morris, C. R. (2006) · Treatments in Respiratory Medicine · doi:10.2165/00151829-200605010-00003 · Cited by 45
Physician‐diagnosed asthma and acute chest syndrome: Associations with NOS Polymorphisms
Duckworth, L. J., Hsu, L. L.-Y., Feng, H., Wang, J., Sylvester, J. E., Kissoon, N. “., Sandler, E. S., & Lima, J. J. (2007) · Pediatric Pulmonology · doi:10.1002/ppul.20582 · Cited by 44
Decreased exhaled nitric oxide in sickle cell disease: Relationship with chronic lung involvement
Girgis, R. E., Qureshi, M. A., Abrams, J., & Swerdlow, P. S. (2003) · American Journal of Hematology · doi:10.1002/ajh.10284 · Cited by 44
Review: Management of Painful Vaso-Occlusive Crisis of Sickle-Cell Anemia: Consensus Opinion
Mousa, S. A., Momen, A. A., Alsayegh, F., Jaouni, S. K. A., Nasrullah, Z., Saeed, H. A., Alabdullatif, A., Sayegh, M. A., Zahrani, H. A., Hegazi, M., et al. (2010) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029609352661 · Cited by 44
Society for Maternal-Fetal Medicine Consult Series #68: Sickle cell disease in pregnancy
Sinkey, R. G., Ogunsile, F. J., Kanter, J., Bean, C., & Greenberg, M. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.10.031 · Cited by 47
Cohen, R. T., DeBaun, M. R., Blinder, M. A., Strunk, R. C., & Field, J. J. (2010) · Blood · doi:10.1182/blood-2010-01-265819 · Cited by 43
Antibiotics for treating acute chest syndrome in people with sickle cell disease
Martí-Carvajal, A. J., Conterno, L. D. O., & Knight‐Madden, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006110.pub4 · Cited by 42
Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease
Novelli, E. M., Kato, G. J., Hildesheim, M. E., Barge, S., Meyer, M. P., Lozier, J. N., Hassett, A. C., Ragni, M. V., Isenberg, J. S., & Gladwin, M. T. (2013) · Haematologica · doi:10.3324/haematol.2013.092635 · Cited by 42
Pack-Mabien, A. V., & Haynes, J. (2009) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2009.00401.x · Cited by 42
Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease
Adamkiewicz, T. V., Mehta, P., Boyer, M. W., Kedar, A., Olson, T. A., Olson, E. A., Chiang, K., MAURER, D. H., Mogul, M. J., Wingard, J. R., et al. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704606 · Cited by 42
Kirkham, F. J., & Datta, A. K. (2006) · Developmental Science · doi:10.1111/j.1467-7687.2006.00507.x · Cited by 41
Inpatient management of sickle cell pain: A ‘snapshot’ of current practice
Miller, S. T., Kim, H., Weiner, D. L., Wager, C. G., Gallagher, D. M., Styles, L. A., & Dampier, C. (2011) · American Journal of Hematology · doi:10.1002/ajh.22265 · Cited by 41
Chaudry, R. A., Rosenthal, M., Bush, A., & Crowley, S. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204464 · Cited by 41
Management of Hemoglobin Disorders During the COVID-19 Pandemic
Chowdhury, S. F., & Anwar, S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00306 · Cited by 41
Clinical presentation of acute chest syndrome in sickle cell disease
Taylor, C. F., Carter, F., Poulose, J., Rolle, S., Babu, S., & Crichlow, S. (2004) · Postgraduate Medical Journal · doi:10.1136/pgmj.2003.012781 · Cited by 41
How we prevent and manage infection in sickle cell disease
Sobota, A. E., Sabharwal, V., Fonebi, G., & Steinberg, M. H. (2015) · British Journal of Haematology · doi:10.1111/bjh.13526 · Cited by 41
Anea, C. B., Lyon, M., Lee, I. A., Gonzales, J. N., Adeyemi, A., Falls, G., Kutlar, A., & Brittain, J. E. (2016) · American Journal of Hematology · doi:10.1002/ajh.24224 · Cited by 40
Surgical Procedures and Outcomes Among Children with Sickle Cell Disease
Hyder, O. N., Yaster, M., Bateman, B. T., & Firth, P. G. (2013) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3182a44d74 · Cited by 40
Ahmad, F. A., Macias, C. G., & Allen, J. Y. (2011) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31821ed4ce · Cited by 40
Measuring success: utility of biomarkers in sickle cell disease clinical trials and care
Kalpatthi, R. V., & Novelli, E. M. (2018) · Hematology · doi:10.1182/asheducation-2018.1.482 · Cited by 47
Farrell, A. T., Panepinto, J. A., Desai, A. A., Kassim, A. A., Lebensburger, J. D., Walters, M. C., Bauer, D. E., Blaylark, R. M., DiMichele, D., Gladwin, M. T., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000883 · Cited by 41
Casella, J. F., BARTON, B. A., Kanter, J., Black, L. V., Majumdar, S., Inati, A. C., Wali, Y. A. M. S., Drachtman, R. A., Abboud, M. R., Kılınç, Y., et al. (2021) · JAMA · doi:10.1001/jama.2021.3414 · Cited by 39
Self-citationSaylors, R. L., Watkins, B. K., Saccente, S. L., & Tang, X. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24744 · Cited by 39
Methacholine challenge in children with sickle cell disease: A case series
Strunk, R. C., Brown, M. S., Boyd, J. H., Bates, P., Field, J. J., & DeBaun, M. R. (2008) · Pediatric Pulmonology · doi:10.1002/ppul.20884 · Cited by 39
Asthma morbidity and treatment in children with sickle cell disease
Anim, S. O., Strunk, R. C., & DeBaun, M. R. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.64 · Cited by 40
Sickle cell disease classification using deep learning
Jennifer, S. S., Shamim, M. H., Reza, A. W., & Siddique, N. H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22203 · Cited by 43
Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease
Paul, R. N., Minniti, C. P., Nouraie, M. S., Luchtman‐Jones, L., Campbell, A., RANA, S. R., Onyekwere, O. C., Darbari, D. S., Ajayi, O., Arteta, M., et al. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12118 · Cited by 38
Hsu, L. L.-Y., Batts, B. K., & Rau, J. L. (2005) · Respiratory Care · doi:10.4187/respcare.05500624 · Cited by 38
Asthma in the pediatric sickle cell patient with acute chest syndrome
Bryant, R. (2005) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2004.12.003 · Cited by 38
THE ROLE OF ATYPICAL PATHOGENS IN COMMUNITY-ACQUIRED PNEUMONIA
Gupta, S. K., & Sarosi, G. A. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70384-9 · Cited by 38
The Burden of Sickle Cell Disease in Saudi Arabia: A Single-Institution Large Retrospective Study
Zuair, A. B., Aldossari, S., Alhumaidi, R., Alrabiah, M., & Alshabanat, A. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s393233 · Cited by 43
Manwani, D. G., Chen, G., Carullo, V. P., Serban, S. I., Olowokure, O. O., Jang, J., Huggins, M. A., Cohen, H. W., Billett, H. H., Atweh, G. F., et al. (2015) · American Journal of Hematology · doi:10.1002/ajh.23956 · Cited by 37
Interfaces for noninvasive ventilation in the acute setting in children
Mortamet, G., Amaddeo, A., Essouri, S., Renolleau, S., Émériaud, G., & Fauroux, B. (2016) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2016.09.004 · Cited by 37
Management of Sickle Cell Disease Complications Beyond Acute Chest Syndrome
Ogu, U. O., Badamosi, N. U., Camacho, P. E., Freire, A. X., & Adams-Graves, P. E. (2021) · Journal of Blood Medicine · doi:10.2147/jbm.s291394 · Cited by 43
Alabdulaali, M. K. (2007) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.36550 · Cited by 37
Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease
Knight‐Madden, J., & Hambleton, I. R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003733.pub4 · Cited by 37
Sarode, R., Ballas, S. K., Garcia, A., Kim, H. C., King, K. E., Sachais, B. S., & Williams, L. A. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21511 · Cited by 37
Self-citationLee, M. T., Kattan, M., Fennoy, I., Arpadi, S. M., Miller, R. L., Cremers, S., McMahon, D. J., Nieves, J. W., & Brittenham, G. M. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017013979 · Cited by 36
COVID-19 and sickle cell disease
Menapace, L. A., & Thein, S. L. (2020) · Haematologica · doi:10.3324/haematol.2020.255398 · Cited by 36
Thrombosis in the pediatric population
Parker, R. I. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c9cce9 · Cited by 36
Induced Sputum versus Bronchoalveolar Lavage during Acute Chest Syndrome in Sickle Cell Disease
Lechapt, E., Habibi, A., Bachir, D., Galactéros, F., Schaeffer, A., Desvaux, D., Brochard, L. J., HOUSSET, B., Godeau, B., & Maître, B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-174oc · Cited by 36
Central Nervous System Complications of Sickle Cell Disease in Children: An Overview
Wang, W. C. (2006) · Child Neuropsychology · doi:10.1080/09297040600788136 · Cited by 36
Bedside Lung Ultrasound During Acute Chest Syndrome in Sickle Cell Disease
Razazi, K., Deux, J., de Prost, N., Boissier, F., Cuquemelle, É., Galactéros, F., Rahmouni, A., Maître, B., Brun‐Buisson, C., & Dessap, A. M. (2016) · Medicine · doi:10.1097/md.0000000000002553 · Cited by 36
Polymerized human Hb use in acute chest syndrome: a case report
Lanzkron, S., Moliterno, A. R., Norris, E. J., Gould, S. A., Segal, J. B., Nuermberger, E. L., & Ness, P. M. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00184.x · Cited by 36
Acute pulmonary complications of sickle cell disease
Knight‐Madden, J., & Greenough, A. (2013) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2013.10.005 · Cited by 35
Novel insights in the management of sickle cell disease in childhood
Iughetti, L. (2016) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v5.i1.25 · Cited by 35
Vital, S. A., Senchenkova, E. Y., Ansari, J., & Gavins, F. N. E. (2020) · Cells · doi:10.3390/cells9112473 · Cited by 35
Walter, O., Cougoul, P., Maquet, J., Bartolucci, P., Lapeyre‐Mestre, M., Lafaurie, M., & Moulis, G. (2022) · Blood · doi:10.1182/blood.2021014473 · Cited by 36
Reagan, M. M., DeBaun, M. R., & Frei‐Jones, M. J. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22808 · Cited by 35
Metadata
- Authors
- Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C., Abboud, M., Moncino, M., Ballas, S., Ware, R., & Manci, E. A.
- Affiliations
- University of California, San Francisco (US)
- Children's Hospital of Orange County (US)
- University of North Carolina at Chapel Hill (US)
- Augusta University (US)
- NewYork–Presbyterian Brooklyn Methodist Hospital (US)
- East Carolina University (US)
- Duke Medical Center (US)
- University of South Alabama Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2000-06-22
- Volume
- 342
- Issue
- 25
- Pages
- 1855-1865
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2332642667
- Cited by
- 1,234
- References
- 44
- Citations by year
- 2026: 35 · 2025: 55 · 2024: 52 · 2023: 62 · 2022: 59 · 2021: 67 · 2020: 75 · 2019: 44 · 2018: 48 · 2017: 38 · 2016: 63 · 2015: 51 · 2014: 57 · 2013: 59 · 2012: 51
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- University of Southern California
- University of Miami
- Emory University
- University of South Alabama
- National Institutes of Health (5p60hl020985-25)
- National Heart, Lung, and Blood Institute (HL20985, HL 99016)
- National Center for Research Resources (M01 RR 01271)
- Children's Hospital of Pittsburgh
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Keywords
- acute chest syndrome, sickle cell disease, pulmonary fat embolism, infection, community-acquired pneumonia, bronchodilators, bronchoscopy, mechanical ventilation, respiratory failure, neurological complications, mortality, hypoxia
- MeSH terms
- Acute Disease, Adolescent, Adult, Anemia, Sickle Cell, Blood Transfusion, Bronchodilator Agents, Chest Pain, Child, Child, Preschool, Embolism, Fat, Female, Humans, Infections, Lung Diseases, Male, Prospective Studies, Pulmonary Embolism, Respiration, Artificial, Respiratory Insufficiency, Proportional Hazards Models, Community-Acquired Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
